Skip to content
RXRX Recursion Pharmaceuticals, Inc. Class A Common Stock
$6.48 1.74% +0.11
Notify me if price changes either direction
Interactive Brokers Logotype

Buy RXRX stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 3.1B
Enterprise value 2B
Trailing PE -4.0696201445181
Forward PE -4.630058
PEG Ratio -4.630058
Enterprise to EBITDA -5.384
Enterprise to revenue 30.077
Price to book MRQ 4.369886
Price to sales TTM 47.794083

Financials

Fiscal Year Ends 2023-12-31
Most Recent Quarter (MRQ) 2024-09-30
Revenue (TTM) 65.2M
EBITDA -364150016
Diluted EPS TTM -1.54
Total Cash (MRQ) 427.6M
Current ratio (MRQ) 4.355
Operating Cash Flow (TTM) -317820992

RXRX trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
75% sells
25% buys
Upgrade Today
In the last 0 months

Recent RXRX News

Sign Up

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

Already have an account?

Services

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.